Doctors Were Chastised For Wellbutrin Claims: GSK Exec

Law360, District of Columbia (May 5, 2011, 6:14 PM EDT) -- GlaxoSmithKline PLC worked with physicians to stop promotion of antidepressant Wellbutrin for off-label uses, a company executive testified Thursday in the Maryland trial of a former GSK attorney who allegedly obstructed a probe into the drug's marketing.

GSK became aware in 2002 that the company's two top promotional-speaker doctors were using slides in their presentations including information for off-label uses of the drug, but swiftly took steps to bring the pair into compliance with all regulations, GSK executive James Millar said in the trial of the...
To view the full article, register now.

Related

Sections

Case Information

Case Title

USA v. Stevens


Case Number

8:10-cr-00694

Court

Maryland

Nature of Suit

Date Filed

November 8, 2010

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.